ProCE Banner Activity

Telemedicine in HCV Care: A Useful Supplement Worth Keeping

Clinical Thought
The COVID-19 pandemic has provided the impetus for nimble and creative strategies that meet patients where they are. In the United States, telemedicine visits are one such strategy—and we should carry them forward in the delivery of care.

Released: September 29, 2021

Expiration: September 28, 2022

No longer available for credit.

Share

Faculty

Stacey Trooskin

Stacey Trooskin, MD, PhD, MPH

Chief Medical Officer
Philadelphia FIGHT Community Health Centers
Faculty
Division of Infectious Diseases
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Educational grants provided by:

AbbVie

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Stacey Trooskin, MD, PhD, MPH

Chief Medical Officer
Philadelphia FIGHT Community Health Centers
Faculty
Division of Infectious Diseases
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

Stacey Trooskin, MD, PhD, MPH, has disclosed that she has received funds for research support and consulting fees from Gilead Sciences.